Continuous Glucose Monitoring Devices Market Size & Share to Surpass $13.24 Bn by 2028 | Vantage Market Research
March 09, 2023 05:25 ET
|
Vantage Market Research
WASHINGTON, March 09, 2023 (GLOBE NEWSWIRE) -- The global Continuous Glucose Monitoring Devices Market is expected to grow at a significant rate over the next few years due to increasing prevalence...
Nemaura Commences Pilot Program of Miboko with the NHS in the United Kingdom
November 29, 2022 08:00 ET
|
Nemaura Medical, Inc
LOUGHBOROUGH, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive...
GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK
October 14, 2022 09:45 ET
|
GlucoTrack, Inc.
INDUSTRY VETERAN TO LEAD NEW CONTINUOUS GLUCOSE MONITORING R&D PROGRAM Rutherford, NJ, Oct. 14, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a...
GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK
October 14, 2022 09:30 ET
|
GlucoTrack, Inc.
INDUSTRY VETERAN TO LEAD NEW CONTINUOUS GLUCOSE MONITORING R&D PROGRAM Rutherford, NJ, Oct. 14, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a...
Nemaura Receives Provisional Purchase Order from Middle East Licensee TPMENA
October 12, 2022 11:00 ET
|
Nemaura Medical, Inc
LOUGHBOROUGH, ENGLAND, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and...
Nemaura Medical Reports Fiscal First Quarter 2023 Results and Provides Business Update
August 15, 2022 08:30 ET
|
Nemaura Medical, Inc
Loughborough, England, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022
June 30, 2022 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, June 30, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding
May 23, 2022 06:30 ET
|
Nemaura Medical, Inc
Loughborough, England, May 23, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
Happy Bob Integrates With Dexcom CGM to Provide a Playful Way to Engage With Real-Time Glucose Values and Improve Overall Self-Care
March 08, 2022 07:00 ET
|
Harald AI
HELSINKI, March 08, 2022 (GLOBE NEWSWIRE) -- Diabetes tech startup Harald AI today introduced a more expansive way for Dexcom Continuous Glucose Monitoring (CGM) System users to engage with their...
Global Continuous Glucose Monitoring Devices (CGM) Market to Hit USD 13.24 Billion by 2028; Continuous Glucose Monitoring Devices Industry CAGR of 10.8% between 2022-2028; Exclusive Insight Report by Vantage Market Research
March 08, 2022 03:12 ET
|
Vantage Market Research
WASHINGTON, March 08, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Continuous Glucose Monitoring Devices Market finds that rising incidence of diabetes is...